Cadrenal Therapeutics, Inc. Common Stock (CVKD) — Cash Flow Reinvestment Rate
Latest as of September 2022:
2.25x
Cadrenal Therapeutics, Inc. Common Stock (CVKD) has a Cash Flow Reinvestment Rate of 2.25x as of September 2022, reinvesting $2.28K (capex $2.28K ) from operating cash flow of $1.01K. Explore Cadrenal Therapeutics, Inc. Common Stock cash flow conversion to assess how effectively this company generates cash.
Reinvestment Rate
2.25x
(Capex + Investments) / Operating CF
Total Reinvested
$2.28K
Capex + Investments
Operating Cash Flow
$1.01K
USD
Capital Expenditures
$2.28K
USD
Annual Cash Flow Reinvestment Rate for Cadrenal Therapeutics, Inc. Common Stock (None–None)
Year-by-year capital reinvestment analysis for Cadrenal Therapeutics, Inc. Common Stock. For live market cap and broader valuation context, see Cadrenal Therapeutics, Inc. Common Stock (CVKD) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow